Navigation Links
Sinovac Provides Support to China's Ministry of Health to Aid Earthquake Victims
Date:5/21/2008

BEIJING, May 21 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced that it is providing immediate support to China's Ministry of Health following the May 12th earthquake in Sichuan province. The assistance is intended to support disease control efforts and includes 50,000 doses of Healive(R), Sinovac's internally developed and commercialized hepatitis A vaccine, as well as RMB 500,000 and the expertise of Sinovac's disease control experts. In addition, Sinovac's employees contributed RMB 110,000 for the Ministry of Health's disease control initiatives.

The Healive supply will be applied to the disaster zone, where the water supply infrastructure has been badly damaged. According to the WHO, hepatitis A is associated with inadequate water supplies and poor sanitation and hygiene, leading to infection and inflammation of the liver. Sinovac believes, because of economies of scale achieved in its Healive manufacturing process, that it can easily make this donation while still being able to meet any additional demand.

Mr. Weidong Yin, Chairman, President and CEO, stated, "While many Chinese companies and citizens are mobilizing to aid the victims of the May 12th earthquake, Sinovac is proud to provide assistance, vaccine donations and financial resources for disease control. Our close coordination with the Ministry of Health on this undertaking underscores our team's extensive scientific and field knowledge about disease prevention and their ability to provide advisory services to raise awareness about disease prevention and the benefits of vaccine administration."

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's commercialized vaccines include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), Anflu(R) (influenza) and Panflu(TM) (H5N1). Sinovac is currently developing Universal Pandemic Influenza vaccine and Japanese encephalitis vaccine. Additional information about Sinovac is available on its website, http://www.sinovac.com . To be added to our distribution list, please email: info@sinovac.com .

For more information, please contact:

Helen G. Yang

Sinovac Biotech Ltd.

Tel: +86-10-8289-0088 Ext. 871

Fax: +86-10-6296-6910

Email: info@sinovac.com

Investors/Media:

Stephanie Carrington/Janine McCargo

The Ruth Group

Tel: 646-536-7017/7033

Email: scarrington@theruthgroup.com

Email: jmccargo@theruthgroup.com


'/>"/>
SOURCE Sinovac Biotech Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Sinovac to Present at the Brean Murray, Carret & Co. Fourth Investor Tour of China
2. Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohns Patients
3. AlphaRx Provides Corporate and Development Update
4. PA Health Department Provides Hepatitis B Vaccinations, Discusses Risk Factors
5. Cipher provides regulatory update for CIP-TRAMADOL ER
6. Innolife Pharma Provides Initial Update on Negotiations for Significant Product Joint Venture
7. InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results
8. Revised AVMA Policy on Castrating and Dehorning Cattle Provides Additional Guidance for Managing Pain
9. Dubai Provides Aid for Cyclone Nargis Victims In Myanmar
10. New Evidence Provides Clinicians With Better Tools to Help Smokers Quit
11. Cholera study provides exciting new way of looking at infectious disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... ... study shows that, although people are taking more steps to protect themselves from sunburn, half ... case of sunburn within the past year. It’s common and people have been dealing with ... recently have people become conscientious of the risks that accompany sunburns. , The team at ...
(Date:7/24/2017)... ... July 24, 2017 , ... A ... focused on delivering end-to-end sleep health care at scale, indicates record-breaking adherence ... that adherence rates for positive airway pressure (PAP) therapy, the most widely utilized ...
(Date:7/24/2017)... ... July 24, 2017 , ... Summer storms are inevitable as weather temperatures in ... often result in massive tree damage requiring emergency tree service. Giroud Tree ... trimming, tree cabling and hazardous tree removal. , “A summer storm is ...
(Date:7/24/2017)... , ... July 24, 2017 , ... “The Perfect Gift”: a customizable and interactive Bible ... Tosha Huckett is a born-again Christian. She has always accepted Christ as her ... Lord. She was in the Spirit when she wrote this book to her children, ...
(Date:7/23/2017)... ... July 24, 2017 , ... Three experts will be interviewed ... Annual Meeting & Exhibition, to be held in Denver, CO on July 30-August ... journalists can visit the AAPM Facebook page to watch three speakers present their ...
Breaking Medicine News(10 mins):
(Date:7/15/2017)... Inc., a Philadelphia -based biotechnology company developing ... completion of a $12.7 million Series A financing round. The ... the participation of existing investors. ... New Ventures III and our current investors, and view the ... our platform technology to transform the course of PD and ...
(Date:7/13/2017)... , July 13, 2017 RK Logistics Group, Inc. ... Pharmacy certification for its Fremont, CA ... in the Tri-Valley and San Jose ... City of Fremont , with its Fremont Innovation District, ... provide such a powerful resource to the hundreds of biotech, ...
(Date:7/11/2017)... Corp., also known as ,The Epigenetics Company, announced today the release of ... using the myDNAge ™ test. Based on Horvath,s Clock, so named ... biostatistics at the David Geffen School of Medicine at UCLA ... ™ technology is used to analyze DNA methylation patterns of over ... Epigenetic ...
Breaking Medicine Technology: